The Hidden Footprint: Measuring and Reducing Scope 3 in Pharma Manufacturing

Scope 3 is most of pharma’s carbon footprint. Who owns cutting it? Value chain experts make the case for a credible strategy.

Register Free: https://www.pharmtech.com/pt_w/Reducing-Scope-3

Event Overview:

Scope 3 emissions account for the majority of a pharmaceutical company’s greenhouse gas footprint, yet they remain the hardest to measure, report, and reduce. Because one organization’s value-chain emissions are another’s direct emissions, sponsors, CDMOs, and suppliers are increasingly negotiating who owns the data and who carries the burden of reductions. In this webinar, experts from the pharmaceutical value chain will discuss where progress is realistic and where it stalls. Topics up for discussion include supplier engagement strategies, data quality and standardized reporting, the role of green chemistry and process design, and the tradeoffs that arise when sustainability goals collide with cost, supply security, and regional manufacturing needs.

Attendees will gain practical perspectives on building credible Scope 3 strategies, evaluating suppliers and partners, and preparing for rising expectations from regulators, investors, and customers.

Key Learning Objectives:

• Explain how Scope 1, 2, and 3 emissions overlap across sponsors, CDMOs, and suppliers, and why that overlap makes responsibility for reductions contested.
• Evaluate the tradeoffs between primary supplier data and estimated or spend-based data when measuring and reporting Scope 3 emissions.
• Identify the highest-impact opportunities for reducing value-chain emissions, including green chemistry, process design, packaging, and supplier engagement.
• Assess how credible net-zero commitments are when Scope 3 reporting is not globally aligned.
• Apply practical criteria for balancing sustainability goals against cost, supply security, and regional manufacturing needs when selecting and managing suppliers and partners.

Who Should Attend:

This Drug Digest episode is best suited for professionals who either report Scope 3 emissions or are asked to help reduce them, especially:

• Sustainability, ESG, and EHS leaders at pharma and biopharma companies, who own reporting and targets.
• Procurement and supply chain leaders, who evaluate suppliers and CDMOs and increasingly see emissions data in sourcing decisions.
• CDMO and CMO executives and operations leaders, who are being asked by sponsors for emissions data and reductions.
• Raw material, API, excipient, and packaging suppliers, who sit upstream and often carry the data burden.
• Process development and manufacturing leaders, who control the green chemistry, continuous manufacturing, and process design levers.
• Regulatory affairs and quality professionals, who need to anticipate reporting expectations and the interplay with compliance.
• Packaging and logistics professionals, since packaging is a significant Scope 3 contributor.
• Senior executives and consultants, who set strategy and advise on net-zero commitments.

Featured Speakers Coming Soon!

Register Free: https://www.pharmtech.com/pt_w/Reducing-Scope-3